Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any acute myeloid leukemia that has the chromosomal anomaly KIT gene mutation. (A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.)
Biomarker and diagnostic research for acute myeloid leukemia, KIT gene mutation has been reported in the published literature.
No clinical trials have been registered for acute myeloid leukemia, KIT gene mutation.
83 publications have been identified in PubMed for acute myeloid leukemia, KIT gene mutation. Research spans Diagnostic / Biomarker (17%), Basic Science / Preclinical (17%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Testing and diagnosis research | 14 | 17% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 8:41 AM UTC
Common questions about acute myeloid leukemia, KIT gene mutation
Laboratory research
14 |
17% |
Disease patterns and progression | 14 | 17% |
Research summaries | 13 | 16% |
Patient case studies | 13 | 16% |
New treatment approaches | 9 | 11% |
Clinical study results | 6 | 7% |
Vasseur L (2026). [PMID: 41888395](https://pubmed.ncbi.nlm.nih.gov/41888395/). *Leukemia*. [Basic Science / Preclinical]
Aqil B (2026). [PMID: 42102664](https://pubmed.ncbi.nlm.nih.gov/42102664/). *Cancer Genet*. [Epidemiology / Natural History]
Liu W (2026). [PMID: 41786054](https://pubmed.ncbi.nlm.nih.gov/41786054/). *Bioorg Med Chem Lett*. [Gene Therapy / Novel Therapeutics]
Döhner H (2026). [PMID: 41490515](https://pubmed.ncbi.nlm.nih.gov/41490515/). *Blood*. [Clinical Trial Publication]
Fareed S (2026). [PMID: 39961289](https://pubmed.ncbi.nlm.nih.gov/39961289/). *Oncology*. [Case Report / Case Series]
Liu L (2026). [PMID: 41874839](https://pubmed.ncbi.nlm.nih.gov/41874839/). *Cancer*. [Diagnostic / Biomarker]
Martín-Herreros B (2026). [PMID: 41689290](https://pubmed.ncbi.nlm.nih.gov/41689290/). *Cytometry B Clin Cytom*. [Diagnostic / Biomarker]
Patel E (2026). [PMID: 41870653](https://pubmed.ncbi.nlm.nih.gov/41870653/). *Ann Hematol*. [Case Report / Case Series]
Liu H (2026). [PMID: 41589893](https://pubmed.ncbi.nlm.nih.gov/41589893/). *Hematology*. [Basic Science / Preclinical]
Mahmood R (2026). [PMID: 42123510](https://pubmed.ncbi.nlm.nih.gov/42123510/). *Int J Mol Sci*. [Basic Science / Preclinical]